1474 SEQUENTIAL CHEMO-IMMUNOTHERAPY WITH MITOMYCIN C (MMC) AND BACILLUS CALMETTE-GUERIN (BCG) VERSUS BCG ALONE IN PATIENTS WITH CARCINOMA IN SITU (CIS) OF THE URINARY BLADDER. RESULTS OF EORTC GU GROUP RANDOMIZED PHASE II STUDY 30993

Ziya Kirkali; Willem Oosterlinck; Richard Sylvester; Fernando Calais Da Silva; Christer Busch; Ferran Algaba; Sandra Collette; Aldo Bono

doi:10.1016/j.juro.2010.02.1189

1474 SEQUENTIAL CHEMO-IMMUNOTHERAPY WITH MITOMYCIN C (MMC) AND BACILLUS CALMETTE-GUERIN (BCG) VERSUS BCG ALONE IN PATIENTS WITH CARCINOMA IN SITU (CIS) OF THE URINARY BLADDER. RESULTS OF EORTC GU GROUP RANDOMIZED PHASE II STUDY 30993

The Journal of Urology ◽

10.1016/j.juro.2010.02.1189 ◽

2010 ◽

Vol 183 (4S) ◽

Author(s):

Ziya Kirkali ◽

Willem Oosterlinck ◽

Richard Sylvester ◽

Fernando Calais Da Silva ◽

Christer Busch ◽

...

Keyword(s):

Urinary Bladder ◽

Mitomycin C ◽

Phase Ii ◽

Carcinoma In Situ ◽

Phase Ii Study ◽

Bacillus Calmette Guerin ◽

Randomized Phase Ii

Download Full-text

189 SEQUENTIAL CHEMO-IMMUNOTHERAPY WITH MITOMYCIN C (MMC) AND BACILLUS CALMETTE-GUERIN (BCG) VERSUS BCG ALONE IN PATIENTS WITH CARCINOMA IN SITU (CIS) OF THE URINARY BLADDER. RESULTS OF EORTC GU GROUP RANDOMIZED PHASE II STUDY 30993

European Urology Supplements ◽

10.1016/s1569-9056(10)60192-3 ◽

2010 ◽

Vol 9 (2) ◽

pp. 91 ◽

Cited By ~ 1

Author(s):

W. Oosterlinck ◽

Z. Kirkali ◽

R.J. Sylvester ◽

F. Calais Da Silva ◽

C. Busch ◽

...

Keyword(s):

Urinary Bladder ◽

Mitomycin C ◽

Phase Ii ◽

Carcinoma In Situ ◽

Phase Ii Study ◽

Bacillus Calmette Guerin ◽

Randomized Phase Ii

Download Full-text

A Phase II Study of Oportuzumab Monatox: An Immunotoxin Therapy for Patients with Noninvasive Urothelial Carcinoma In Situ Previously Treated with Bacillus Calmette-Guérin

The Journal of Urology ◽

10.1016/j.juro.2012.07.020 ◽

2012 ◽

Vol 188 (5) ◽

pp. 1712-1718 ◽

Cited By ~ 44

Author(s):

Mark Kowalski ◽

Jacinthe Guindon ◽

Louise Brazas ◽

Celine Moore ◽

Joycelyn Entwistle ◽

...

Keyword(s):

Urothelial Carcinoma ◽

Phase Ii ◽

Carcinoma In Situ ◽

Phase Ii Study ◽

Bacillus Calmette Guerin ◽

Previously Treated

Download Full-text

Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette-Guérin and with Bacillus Calmette-Guérin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial (30993)

European Urology ◽

10.1016/j.eururo.2010.11.038 ◽

2011 ◽

Vol 59 (3) ◽

pp. 438-446 ◽

Cited By ~ 34

Author(s):

Willem Oosterlinck ◽

Ziya Kirkali ◽

Richard Sylvester ◽

Fernando Calais da Silva ◽

Christer Busch ◽

...

Keyword(s):

Urinary Bladder ◽

Mitomycin C ◽

Carcinoma In Situ ◽

Phase 2 ◽

Bacillus Calmette Guerin ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)

International braz j urol ◽

10.1590/s1677-55382011000200024 ◽

2011 ◽

Vol 37 (2) ◽

pp. 281-282

Author(s):

Andreas Bohle

Keyword(s):

Urinary Bladder ◽

Mitomycin C ◽

Carcinoma In Situ ◽

Phase 2 ◽

Bacillus Calmette Guerin ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

Commentary on “A phase II study of oportuzumab monatox: An immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guérin.” Kowalski M, Guindon J, Brazas L, Moore C, Entwistle J, Cizeau J, Jewett MA, MacDonald GC

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2013.03.016 ◽

2013 ◽

Vol 31 (5) ◽

pp. 714

Author(s):

William A. See

Keyword(s):

Urothelial Carcinoma ◽

Phase Ii ◽

Carcinoma In Situ ◽

Phase Ii Study ◽

Bacillus Calmette Guerin ◽

Previously Treated

Download Full-text

Re: Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al. Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette-Guérin and with Bacillus Calmette-Guérin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial (30993). Eur Urol 2011;59:438–46

European Urology ◽

10.1016/j.eururo.2011.03.050 ◽

2011 ◽

Vol 60 (1) ◽

pp. e1 ◽

Cited By ~ 1

Author(s):

Wei Ling Ooi ◽

Martin Stockler ◽

Dickon Hayne

Keyword(s):

Urinary Bladder ◽

Mitomycin C ◽

Carcinoma In Situ ◽

Phase 2 ◽

Bacillus Calmette Guerin ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

Intravesical Mitomycin C for Carcinoma in situ of the Urinary Bladder

Scandinavian Journal of Urology and Nephrology ◽

10.3109/00365599009180357 ◽

1990 ◽

Vol 24 (1) ◽

pp. 35-38 ◽

Cited By ~ 4

Author(s):

S. Hellsten ◽

W. Månsson ◽

H. Henrikson ◽

I. Idwall ◽

K. Lindholm ◽

...

Keyword(s):

Urinary Bladder ◽

Mitomycin C ◽

Carcinoma In Situ

Download Full-text

Original Articles: Bladder Cancer: A Randomized Study of Intravesical Mitomycin C, Bacillus Calmette-Guerin Tice and Bacillus Calmette-Guerin RIVM Treatment in pTa-pT1 Papillary Carcinoma and Carcinoma in Situ of the Bladder

The Journal of Urology ◽

10.1016/s0022-5347(01)67606-7 ◽

1995 ◽

Vol 153 (3S) ◽

pp. 929-933 ◽

Cited By ~ 84

Author(s):

Peter D.J. Vegt ◽

J. Alfred Witjes ◽

Wim P.J. Witjes ◽

Wim H. Doesburg ◽

Frans M.J. Debruyne ◽

...

Keyword(s):

Bladder Cancer ◽

Papillary Carcinoma ◽

Mitomycin C ◽

Carcinoma In Situ ◽

Randomized Study ◽

Bacillus Calmette Guerin

Download Full-text

Clinical outcomes of bacillus Calmette-Guérin instillation therapy for carcinoma in situ of urinary bladder

International Journal of Urology ◽

10.1111/j.1442-2042.2008.02012.x ◽

2008 ◽

Vol 15 (4) ◽

pp. 309-313 ◽

Cited By ~ 33

Author(s):

Atsushi Takenaka ◽

Yuji Yamada ◽

Hideaki Miyake ◽

Isao Hara ◽

Masato Fujisawa

Keyword(s):

Urinary Bladder ◽

Clinical Outcomes ◽

Carcinoma In Situ ◽

Bacillus Calmette Guerin ◽

Instillation Therapy

Download Full-text

429 NEOADJUVANT INTENSIVE INTRAVESICAL MITOMYCIN C REGIMEN VERSUS STANDARD SCHEDULE FOR NON MUSCLE INVASIVE BLADDER CANCER. RANDOMIZED PHASE II STUDY

European Urology Supplements ◽

10.1016/s1569-9056(11)60422-3 ◽

2011 ◽

Vol 10 (2) ◽

pp. 148

Author(s):

L. Rocchini ◽

F. Pellucchi ◽

B. Ibrahim ◽

C. Maccagnano ◽

M. Freschi ◽

...

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Phase Ii ◽

Phase Ii Study ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Randomized Phase Ii ◽

Muscle Invasive

Download Full-text